Ro.co vs Maximus: Wegovy Pill or Compounded Semaglutide Choice
Ro.co vs Maximus is a contrast between a mainstream platform offering the FDA-approved Wegovy pill and a direct-pay telemedicine provider focused on compounded semaglutide. Early verdict: choose Ro.co if you prioritize an FDA-approved oral GLP-1 and brand trust; choose Maximus if you prioritize a lower flat monthly price for compounded semaglutide.
Get started with Ro.co for $39
Quick comparison highlights: Ro.co vs Maximus
This comparison uses only supplied facts. The clearest differences are product type and regulatory status, pricing model, and pharmacy sourcing and scale. Both operate via licensed clinician review and telemedicine access, but they serve different priorities.
1. Product type and regulatory status
Ro.co: The platform is noted as the only mainstream provider on this list offering the Wegovy pill, an FDA-approved oral GLP-1 finished medication. The source emphasizes that the Wegovy pill is not compounded and that Ro provides a path to a branded oral option, subject to a licensed clinician determining it is medically appropriate. The source also states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Maximus: Offers compounded semaglutide, filled through trusted U.S. pharmacies and prescribed by licensed doctors. The provider uses the same active ingredient as branded GLP-1 products, but the medication is compounded, and the captured evidence repeats the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
2. Pricing and payment model
Ro.co: Advertising highlights “Get Started Online for Just $39” as a direct-pay entry point. The source notes that ongoing branded medication pricing can be significantly higher than compounded alternatives and that Ro discloses pricing before you complete your consultation.
Maximus: Uses a straightforward direct-pay model with a low flat rate listed as $132.99 per month. The landing details mention a range of starting points and that there is no insurance billing. Maximus describes itself as one of the lower flat rates on the list.
3. Pharmacy sourcing, shipping, and availability
Ro.co: Emphasizes FDA-approved finished medication access rather than compounded products. The captured page did not verify shipping, fees, membership, or cancellation details.
Maximus: States prescriptions are filled through trusted U.S. pharmacies and advertises free priority or expedited shipping in captured landing content. Maximus also lists availability in all 50 states except Mississippi in the captured evidence.
4. Scale, track record, and platform positioning
Ro.co: Described as an established, full-service telehealth platform with strong brand trust and multiple service lines. The source frames Ro as one of the first mainstream platforms to gain oral GLP-1 access at scale.
Maximus: Presented as a newer, smaller platform with a smaller patient base and fewer public reviews. The source positions Maximus as best for cost-driven patients comfortable with a newer platform.
Side-by-side at-a-glance table
| Criteria | Ro.co | Maximus |
|---|---|---|
| Primary product | Wegovy pill, FDA-approved oral GLP-1 | Compounded semaglutide |
| Starting price cited | Get Started Online for Just $39 | $132.99 per month |
| Regulatory note | Uses FDA-approved finished medication; compounded meds not FDA-reviewed | Medication compounded; compounded meds not FDA-reviewed |
| Pharmacy sourcing | Not specified on captured page | Filled through trusted U.S. pharmacies |
| Best for | Online GLP-1 weight loss care, injection-averse patients | Cost-driven patients seeking compounded semaglutide |
Patient experience notes from sources
Ro.co: The source states Ro does not charge hidden fees and discloses pricing before you complete your consultation. Access to Wegovy is subject to licensed clinician review and medical appropriateness.
Maximus: The source says prescriptions are approved by licensed doctors with no in-person visit required, and that if you are not approved for treatment, medication costs will be fully refunded. Maximus allows custom titration for non-starter packs included in the listed monthly or quarterly price.
Start Maximus at $132.99/month
How to decide: core trade offs
If having an FDA-approved, oral GLP-1 pill and the regulatory clarity of a branded finished product matters most, Ro.co is the supplied choice. If a lower flat monthly rate for compounded semaglutide, straightforward direct-pay pricing, and U.S. pharmacy fulfillment are your priority, Maximus is the supplied option.
See Maximus compounded semaglutide details
Choose one based on the source
Choose Ro.co if you want access to an FDA-approved oral GLP-1 and prefer a well established telehealth platform. Choose Maximus if you want a lower flat monthly price for compounded semaglutide prescribed via telemedicine and filled through U.S. pharmacies.
Ro.co vs Maximus: both provide licensed clinician review and telemedicine access, but they differ on medication type, pricing structure, and scale. Review the provider evidence above and pick the option aligned with your priorities.